Effective and selective targeting of Ph(+) leukemia cells using a TORC1/2 kinase inhibitor

Targeting the mammalian target of rapamycin (mTOR) is a promising strategy for cancer therapy. However, the mTOR kinase functions in two complexes, TORC1 and TORC2, neither of which is fully inhibited by the allosteric inhibitor rapamycin or analogs. We compared rapamycin with the active-site TORC1/...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Janes, Matthew R., Limon, Jose J., So, Lomon, Chen, Jing, Lim, Raymond J., Chavez, Melissa A., Vu, Collin, Lilly, Michael B., Mallya, Sharmila, Ong, S. Tiong, Marina, Konopleva, Martin, Michael B., Ren, Pingda, Liu, Yi, Rommel, Christian, Fruman, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017764/
https://ncbi.nlm.nih.gov/pubmed/20072130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.2091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados